Product Information
TICAGRELOR 90 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.2634 per EA under NDC 72205036891. Its NADAC has been published 58 times since Jul 16, 2025.
FDA first approved this application on Apr 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the TICAGRELOR market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
90 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205036891
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TICAGRELORApproval Type
Generic (ANDA)
FDA Application
ANDA208596FDA Approved
4/7/2020
TE Code
AB
On Market Since
4/7/2020
Pharmacological Classes
Price Statistics
The NADAC for TICAGRELOR 90 MG TABLET has been published 58 times since Jul 16, 2025, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2634 per EA |
|---|---|
| All-time high | $0.4640 (Nov 12, 2025) |
| All-time low | $0.2634 (Aug 19, 2026) |
| 52-week high | $0.4640 |
| 52-week low | $0.2634 |
| Median price | $0.4030 |
| Average price | $0.3777 |
| Largest weekly change | -13.1% (Feb 18, 2026) |
| Weeks tracked | 58 |
| Tracking since | Jul 16, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TICAGRELOR 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TICAGRELOR 90 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.2634 per EA (NDC 72205036891), effective Aug 19, 2026.
How has the price of TICAGRELOR 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for TICAGRELOR 90 MG TABLET has declined 34.6%. It has been tracked across 58 weekly CMS publications since Jul 16, 2025.
What are the highest and lowest recorded NADAC prices for TICAGRELOR 90 MG TABLET?
Since Jul 16, 2025, the NADAC for TICAGRELOR 90 MG TABLET has ranged from a low of $0.2634 (Aug 19, 2026) to a high of $0.4640 (Nov 12, 2025), with a median of $0.4030 per EA.
Are there cheaper alternatives to TICAGRELOR 90 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TICAGRELOR 90 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TICAGRELOR 90 MG TABLET?
TICAGRELOR 90 MG TABLET (NDC 72205036891) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.